Background Alcohol use disorder is highly prevalent and has important economical,
societal, psychiatric, and medical consequences. All currently approved therapeutic …

Substance use disorder (SUD) is a global public health concern that affects millions of
people worldwide. Considering current research, addiction has been noted as the last stage …

Eating disorders (EDs) are serious, life-threatening psychiatric conditions associated with
physical and psychosocial impairment, as well as high morbidity and mortality. Given the …

Alcohol use disorder (AUD) is a chronic, recurrent condition that demonstrates significant
heterogeneity in treatment response to first-line agents. Ketamine may have a therapeutic …

Substance-related disorders are complex psychiatric disorders that are characterized by
continued consumption in spite of harmful consequences. Addiction affects various brain …

Drug abuse has become a public health concern. The misuse of ketamine, a psychedelic
substance, has increased worldwide. In addition, the co-abuse with alcohol is frequently …

Background Previous research has demonstrated the utility of subanesthetic doses of
ketamine in decreasing binge (Drinking-in-the-Dark, or DID) 20% alcohol intake in female …

Treatment-resistant depression (TRD) is a problematic and prevalent public health and
societal concern. Although electroconvulsive therapy (ECT) is the gold standard TRD …

Abstract Purpose of Review This review summarizes recent clinical trial research on
pharmacological treatments for substance use disorders, with a specific focus on agents with …

Le Trouble de l'Usage d'Alcool (TUA) est une maladie psychiatrique caractérisée par une
consommation chronique et excessive d'alcool malgré des conséquences négatives sur la …